Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
My 28th Feb urine sample for bladder cancer molecular marker, CxBladder, has again shown a very low value – that is, no evidence of bladder cancer.
So now I just have to worry about my stressed kidney and hypertension (somewhat interconnected).
My blood pressure has surged as I weaned myself off the last pill I was taking (2mg perindopril, down from 6mg), having dropped amlopodine over a week ago and bisoprolol a month ago). So I’ll probably restart the minimal perindopril soon.
Meanwhile my kidney function, as indicated by my cystatin-c result, isn’t improving despite my having found a bad correlation between the hypertension pills and this marker. So that shows correlation is not causation in this case.
Scientists at Northeastern University have discovered that supplemental oxygenation can shrink tumors and may improve cancer immunotherapy.
05.03.2015 - Bavarian Nordic is outlicensing its Phase 3 prostate cancer immunotherapy Prostvac to pharma heavyweight Bristol Myers Squibb for a ...
“Cancer immunotherapy continues to be one of the most exciting approaches to treating cancer, but also one that is rapidly evolving. Application of ...
Immunotherapy is a promising area of cancer research. It differs from chemotherapy, which destroys cancer cells, and unfortunately, other cells; ...
LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo - Virtual Press Office (press release)
Advaxis is a clinical-stage biotechnology company developing multiple cancer immunotherapies based on its proprietary Lm-LLO platform technology.
Older white males with advanced bladder cancer are the most likely to commit suicide among patients with genitourinary cancers, according to a ...
Systemic chemotherapy is the standard treatment of advanced and metastatic urothelial carcinoma of the bladder (UCB). Unfortunately, systemic ...
... cisplatin-based combination chemotherapy remains the standard of care for surgically fit patients with muscle-invasive bladder cancer (MIBC).
Cost-effectiveness of transurethral resection of the bladder with blue light in patients with non muscle invasive bladder cancer in France - Abstract.
FDA Approves Nivolumab (Opdivo) for NSCLC
The FDA has approved nivolumab (Opdivo) for the treatment of metastatic squamous non-small cell-lung cancer (NSCLC) in patients who have progressed on a platinum-based chemotherapy.
The FDA has approved nivolumab (Opdivo) for the treatment of metastatic squamous non-small cell-lung cancer (NSCLC) in patients who have progressed on a platinum-based chemotherapy.
Protecting Ovary Function During Breast Cancer Chemotherapy
The risk of early, sudden-onset menopause in women treated for early-stage breast cancer can be reduced with goserelin, a gonadotropin-releasing hormone agonist.
The risk of early, sudden-onset menopause in women treated for early-stage breast cancer can be reduced with goserelin, a gonadotropin-releasing hormone agonist.
Personalized T-Cell Therapy for Brain Cancer
Researchers have shown that reprogramming T cells to target glioblastoma in mice resulted in control of these tumors.
Researchers have shown that reprogramming T cells to target glioblastoma in mice resulted in control of these tumors.
Maintenance Sunitinib Improved PFS in Extensive-Stage SCLC
In a phase II study, the use of maintenance sunitinib improved progression-free survival among patients with untreated extensive-stage small-cell lung cancer.
In a phase II study, the use of maintenance sunitinib improved progression-free survival among patients with untreated extensive-stage small-cell lung cancer.
Science Daily Cancer News
For the first time, CRISPR-Cas9 gene-editing technology has been employed in a whole organism model to systematically target every gene in the genome. A team of scientists has pioneered the use of this technology to 'knock out,' or turn off, all genes across the genome systematically in an animal model of cancer, revealing genes involved in tumor evolution and metastasis and paving the way for similar studies in other cell types and diseases.
Women who smoke when pregnant are putting their daughters at a greater risk of developing ovarian and breast cancer later in life, a new study has determined. Findings also demonstrated that mothers who reported smoking most days while pregnant had daughters who had an earlier age of first menstruation, or menarche.
An extraordinary self-regulating heating effect that can be achieved in a particular type of magnetic material may open the doors to a new strategy for hyperthermia cancer treatment, researchers say. "This strong, self-regulated heating effect is unmatched by other materials," an investigator said. "It opens a novel design strategy for realising in vivo hyperthermia therapy."
Nanoparticles can function as carriers for medicines to combat lung cancer, scientists say, after developing nanocarriers that site-selectively release medicines/drugs at the tumor site in human and mouse lungs. The scientists report that this approach led to a significant increase in the effectiveness of current cancer medicines in lung tumor tissue.
Melanoma in some adolescent and adult patients involves many of the same genetic alterations and would likely respond to the same therapy, researchers have found. "Until now the genetic basis of pediatric melanoma has been a bit of a mystery," said a co-corresponding author. "With this study, we have established the molecular signatures of the three subtypes of this cancer, signatures that have implications for diagnosis and treatment."
Early menopause can be prevented and fertility may be preserved in young women with early stage breast cancer, according to a study. A major international clinical trial has found that the risk of sudden onset of menopause can be significantly reduced by adding a drug called goserelin to the chemotherapy regimen. Women who took goserelin and wanted to have children also were more likely to get pregnant and deliver a healthy baby.
Supplemental oxygenation could shrink tumors and improve cancer immunotherapy, researchers have discovered. "The anti-tumor effects of supplemental oxygen can be further improved by the natural antagonist of the A2A adenosine receptor, which happens to be the caffeine in your coffee," the lead researcher said. "People drink coffee because caffeine prevents the A2A adenosine receptor in the brain from putting us to sleep."
Tambahkan Komentar